Dowling & Yahnke’s NuVasive, Inc. NUVA Stock Holding History

Dowling & Yahnke’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2,748	Closed	-$211K	–	285
2017 Q2	$211K	Hold	2,748	–	–	0.02%	265
2017 Q1	$205K	Buy	+2,748	New	+$199K	0.02%	265

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Dowling & Yahnke's NUVA Position: Q3 2017 in Review

Dowling & Yahnke sold out of NuVasive, Inc. (NUVA) in Q3 2017, closing a stake of 2,748 shares — an estimated $211K sold.

Dowling & Yahnke first reported a position in NUVA in Q1 2017 and held it in 2 quarters. The position peaked at $211K in Q2 2017. 263 funds tracked by Wall St. Rank hold NUVA as of Q3 2017.

Dowling & Yahnke reported no remaining NuVasive, Inc. position as of Q3 2017 after selling out during the quarter.
Dowling & Yahnke sold 2,748 NuVasive, Inc. shares in Q3 2017, an estimated $211K.
Dowling & Yahnke first reported a position in NuVasive, Inc. in Q1 2017 and held it in 2 quarters.
Dowling & Yahnke's NuVasive, Inc. position peaked at $211K in Q2 2017.
263 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2017.

Based on Dowling & Yahnke's 13F filing for Q3 2017, filed 8 Nov 2017.